China's first LILANSSI dextran microsurgery was successfully carried out at Boao Yiling Life Care Center on Aug 23, 2020.

MEPION (Korea Mopei), a factory owned by South Korea's LIDEX, has launched the world's first LILANSSI GEM HARD tissue repair material (cross-linked glucan) product, which is well-known in the global medical industry. It has a lot of advantages such as being safe, having long-lasting effects, being strong and stable, and having a wide range of uses.